Conference Coverage
Conference Coverage
Statins’ effects on CVD outweigh risk for diabetes in RA
A large cohort study reports that the cardiovascular benefits of statin use in people with rheumatoid arthritis outweigh the moderate diabetes...
Conference Coverage
‘If obesity were diabetes or cancer, how would you approach it?’
There’s so much misinformation about obesity, says an expert. ‘People think it’s a lack of willpower, and even patients blame themselves for not...
Conference Coverage
SUGAR trial finds superior stent for those with diabetes and CAD
In noninferiority trial, the Cre8 EVO stent was associated with fewer target lesion failures than the Resolute Onyx at 1 year in the setting of...
Conference Coverage
What are the cardiorenal differences between type 1 and type 2 diabetes?
Heart failure may be as much, if not more of, a problem in people with type 1 diabetes as type 2 diabetes, researchers suggested.
Conference Coverage
Estimating insulin resistance may help predict stroke, death in T2D
The estimated glucose disposal rate may be useful way to determine first stroke risk in type 2 diabetes.
Conference Coverage
Dropping weight beneficial but some effects of obesity persist
People with healthy BMIs who report former obesity have a lingering, elevated prevalence of type 2 diabetes, according to data from a series of...
Conference Coverage
‘Push the bar higher’: New statement on type 1 diabetes in adults
“The focus on adults is kind of new and it is important. ... I do think it’s a bit of a forgotten population,” says coauthor Dr. M. Sue Kirkman....
Conference Coverage
Hypoglycemia awareness program helps tricky-to-treat T1D
New psychoeducation program tackles problematic type 1 diabetes hypoglycemia awareness, reducing severe hypoglycemia with added mental health...
Conference Coverage
Primary goal in T2D should be weight loss, diabetologists say
Four diabetes and obesity experts make the case for targeting weight loss of at least 15% as a frontline treatment goal for many patients with...
Conference Coverage
TriMaster study shows precision medicine in diabetes is possible
The novel TriMaster trial of three type 2 diabetes drug classes shows different ones work better for different patients.